These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 8791979)

  • 1. Cushing's syndrome and hypothalamic-pituitary adrenal axis suppression induced by medroxyprogesterone acetate.
    Malik KJ; Wakelin K; Dean S; Cove DH; Wood PJ
    Ann Clin Biochem; 1996 May; 33 ( Pt 3)():187-9. PubMed ID: 8791979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of progestin administration on the hypothalamic-pituitary-adrenal axis and glucose homeostasis in dogs.
    Selman PJ; Mol JA; Rutteman GR; van Garderen E; van den Ingh TS; Rijnberk A
    J Reprod Fertil Suppl; 1997; 51():345-54. PubMed ID: 9404305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prescription of medroxyprogesterone acetate to a patient with pedophilia, resulting in Cushing's syndrome and adrenal insufficiency.
    Krueger RB; Hembree W; Hill M
    Sex Abuse; 2006 Apr; 18(2):227-8. PubMed ID: 16868842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cushing's syndrome with suppression of the hypothalamic-pituitary-adrenal axis after intra-articular steroid injections.
    O'Sullivan MM; Rumfeld WR; Jones MK; Williams BD
    Ann Rheum Dis; 1985 Aug; 44(8):561-3. PubMed ID: 4026419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medroxyprogesterone acetate induced Cushing's syndrome.
    Shotliff K; Nussey SS
    Br J Clin Pharmacol; 1997 Sep; 44(3):304. PubMed ID: 9296330
    [No Abstract]   [Full Text] [Related]  

  • 6. Progestogens and Cushing's syndrome.
    Harte C; Henry MT; Murphy KD; Mitchell TH
    Ir J Med Sci; 1995; 164(4):274-5. PubMed ID: 8522428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cushing's syndrome with adrenal suppression and masked hyperandrogenism by high-dose medroxyprogesterone acetate for treatment of endometrial cancer in a young woman with polycystic ovarian syndrome.
    Seo Y; Jeong EG; Kim ES
    Endocrine; 2015 Nov; 50(2):519-21. PubMed ID: 26298265
    [No Abstract]   [Full Text] [Related]  

  • 8. Hypothalamo-pituitary-adrenal axis in iatrogenic Cushing's syndrome.
    Tsan KW; Kuo CY
    Taiwan Yi Xue Hui Za Zhi; 1985 Aug; 84(8):936-43. PubMed ID: 3001216
    [No Abstract]   [Full Text] [Related]  

  • 9. The effect of pulsatile human corticotropin-releasing hormone administration on the adrenal insufficiency that follows cure of Cushing's disease.
    Avgerinos PC; Nieman LK; Oldfield EH; Loughlin T; Barnes KM; Loriaux DL; Cutler GB
    J Clin Endocrinol Metab; 1989 May; 68(5):912-6. PubMed ID: 2541160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medroxyprogesterone induced Cushing's syndrome.
    Learoyd D; McElduff A
    Aust N Z J Med; 1990 Dec; 20(6):824-5. PubMed ID: 1963297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Megestrol acetate therapy and secondary adrenal suppression.
    Naing KK; Dewar JA; Leese GP
    Cancer; 1999 Sep; 86(6):1044-9. PubMed ID: 10491532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of loperamide on the human hypothalamo-pituitary-adrenal axis in vivo and in vitro.
    Auernhammer CJ; Stalla GK; Lange M; Pfeiffer A; Müller OA
    J Clin Endocrinol Metab; 1992 Aug; 75(2):552-7. PubMed ID: 1322429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of medroxyprogesterone acetate on the pituitary-adrenal axis.
    Hellman L; Yoshida K; Zumoff B; Levin J; Kream J; Fukushima DK
    J Clin Endocrinol Metab; 1976 May; 42(5):912-7. PubMed ID: 178684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Itraconazole and inhaled fluticasone causing hypothalamic-pituitary-adrenal axis suppression in adults with cystic fibrosis.
    Gilchrist FJ; Cox KJ; Rowe R; Horsley A; Webb AK; Jones AM; Bright-Thomas RJ
    J Cyst Fibros; 2013 Jul; 12(4):399-402. PubMed ID: 23276699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The corticotropin-releasing hormone test in the postoperative evaluation of patients with cushing's syndrome.
    Avgerinos PC; Chrousos GP; Nieman LK; Oldfield EH; Loriaux DL; Cutler GB
    J Clin Endocrinol Metab; 1987 Nov; 65(5):906-13. PubMed ID: 3499448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of ACTH by cortisol in dexamethasone-nonsuppressible Cushing's disease.
    Carey RM
    N Engl J Med; 1980 Jan; 302(5):275-9. PubMed ID: 6243171
    [No Abstract]   [Full Text] [Related]  

  • 17. Response of serum macrophage migration inhibitory factor levels to stimulation or suppression of the hypothalamo-pituitary-adrenal axis in normal subjects and patients with Cushing's disease.
    Isidori AM; Kaltsas GA; Korbonits M; Pyle M; Gueorguiev M; Meinhardt A; Metz C; Petrovsky N; Popovic V; Bucala R; Grossman AB
    J Clin Endocrinol Metab; 2002 Apr; 87(4):1834-40. PubMed ID: 11932327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of iatrogenic Cushing syndrome: questions of glucocorticoid withdrawal].
    Igaz P; Rácz K; Tóth M; Gláz E; Tulassay Z
    Orv Hetil; 2007 Feb; 148(5):195-202. PubMed ID: 17344139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alcohol-induced pseudo-Cushing's syndrome.
    Jeffcoate W
    Lancet; 1993 Mar; 341(8846):676-7. PubMed ID: 8095582
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of aminoglutethimide on hypothalamic-pituitary-adrenal functions.
    Pan CY; Luo GC; Li JY; Wang YZ; Lu SZ; Ma SQ; Guo AY
    Chin Med J (Engl); 1989 Nov; 102(11):890-4. PubMed ID: 2561555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.